Risk factor
Considerable default risk
Profitability factor
Greatly overvalued vs peers
About
Polski Bank Komórek Macierzystych S.A. operates an umbilical cord blood stem cell bank. The company operates through Afterbirth Tissues Banking B2C Services, Afterbirth Tissue Banking B2B Market, and R&D Activities segments. It engages in the processing and storage of human biological material for individual customers and business partners. The company provides diagnostic services; and operates one day hospital and a cell and tissue bank. It also operates diagnostic laboratory and ultrasound scan clinics; operates web portal and provides marketing activities; and conducts research activities. The company offers its services in Serbia, Sweden, Denmark, Ukraine, Germany, and the United States, as well as various Balkan countries and Egypt. Polski Bank Komórek Macierzystych S.A. was founded in 2002 and is based in Warsaw, Poland. Polski Bank Komórek Macierzystych S.A. operates as a subsidiary of AOC Health GmbH.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E.